Clinical

Dataset Information

Evaluation of the immune-profiling for patients participating in Phase Ib/II Study of BBI608 in Combination with Pembrolizumab and the relationship between the immune-profiling and efficacy using paired biopsies and peripheral blood.


ABSTRACT: Primary outcome(s): Evaluation of the immune-profiling.

DISEASE(S): Metastatic Colorectal Cancer

PROVIDER: 2639746 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR